Sequella Inc., a clinical-stage company focused drugs to treat infectious diseases, has added John Friedman as an independent director. Friedman is the founding and managing partner of Easton Capital Investment Group. He was previously a founder and managing general partner of Security Pacific Capital Investors, a $200-million private equity fund.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
